Transparency in clinical trials is continually changing, and to stay on top of the news, TrialAssure brings a weekly round-up of some of the key stories from the last few weeks, as follows:

EMA Management Board: Highlights of December 2019 meeting – European Medicines Agency

The Dutch government hosted the EMA’s Management Board December meeting. Topics discussed included the 2020 EMA budget, EU cooperation on medicines’ availability, updates on the EU IT systems required by the Clinical Trial Regulation, and more.

View the full press release here

AATS calls for transparency of clinical research data –

The American Association for Thoracic Surgery (AATS) released a statement in response to continued discussion on the validity of the results of a specific clinical trial. AATS is calling for the full release of the clinical data, so surgeons and patients can make informed choices.

Read the article, reviewed by Kate Anderton, here

Pressure grows on German regulators and universities to make clinical trial results public – TranspariMED

A recent report by TranspariMED and BUKO Pharma-Kampagne showed that some German universities failed to properly report clinical trial results. After widespread media coverage the report generated, German regulatory and medical bodies are pressuring the universities to make clinical trial results public.

Read Till Bruckner’s piece covering this issue modernization RFI –

The National Library of Medicine (NLM) has issued a request for information (RFI) as part of its multi-year modernization initiative for Additionally, interested individuals can join a webinar on January 22 to learn more about the initiative.

Get all the updates on

< Back to Blog